Detailed Information on Publication Record
2001
Epibatidine and analogs - New trends in the development of cognitive enhancers and strong analgetics
PATOČKA, Jiří, Kräuff SCHWANHAEUSER WULFF and María Victoria MARINI PALOMEQUEBasic information
Original name
Epibatidine and analogs - New trends in the development of cognitive enhancers and strong analgetics
Name in Czech
Epibatidine a jeji analogy - Novy trendy
Authors
PATOČKA, Jiří (203 Czech Republic), Kräuff SCHWANHAEUSER WULFF (170 Colombia, guarantor) and María Victoria MARINI PALOMEQUE (858 Uruguay)
Edition
Vojenské zdravotnické listy, Hradec Králové, Czech Republic, Vojenská lékařská akademie J.E. Purkyně, 2001, 0372-7025
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30104 Pharmacology and pharmacy
Country of publisher
Czech Republic
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Organization unit
Faculty of Medicine
Keywords in English
epibatidine;analgetics;poison-dart frog; alkaloid; nicotinic acetylcholine agonist;dementia;Alzheimer's disease;pain;toxin
Tags
Tags
International impact, Reviewed
Změněno: 25/1/2008 17:29, MUDr. Kräuff Rainer Schwanhaeuser Wulff, MBA, Ph.D. et Ph.D., M.A.
V originále
Epibatidine, the natural alkaloid isolated from the skin of the Ecuatorian rainforest poison-dart frog. Epipedobates tricolor and some of its synthetically prepared analogs are strong selective agonists of the nicotinic acetylcholine receptors. All of these substances have an analgesic effect and could be used in medical practice. This is very promising for medicine in the fight against pain as well as against dementia, because nicotinic agonists have been found to improve the performance of a variety of memory tasks in rodents and they are probably beneficial in Alzheimer's disease treatment.
In Czech
Epibatidine, the natural alkaloid isolated from the skin of the Ecuatorian rainforest poison-dart frog. Epipedobates tricolor and some of its synthetically prepared analogs are strong selective agonists of the nicotinic acetylcholine receptors. All of these substances have an analgesic effect and could be used in medical practice. This is very promising for medicine in the fight against pain as well as against dementia, because nicotinic agonists have been found to improve the performance of a variety of memory tasks in rodents and they are probably beneficial in Alzheimer's disease treatment.